1808 Nakaizumi, Iwata-shi, Shizuoka 438-0078, Japan (Received for publication September 26, 2003) In the course of screening program for inhibitors of angiogenesis, novel substances designated as ICM0301A-H (1-8) were isolated from the culture broth of Aspergillus sp. F-1491. ICM0301s inhibited the growth of human umbilical vein endothelial cells (HUVECs) angiogenesis model using rat aorta cultured in fibrin gel. ICM0301s showed very low cytotoxicity against various tumor cells. Furthermore, ICM0301A did not show any toxic symptom in mice by intraperitoneal injection at 100mg/kg.
Angoogenesis is the process of the formation of new blood vessels from preexisting blood vessels1,2). This process plays a key role in the development and wound healing. Furthermore, angiogenesis is essential for the development of solid tumor3), metastasis of tumors cells4) and chronic inflammation such as rheumatoid arthritis5).
The process of angiogenesis6,7) consists of: (i) degradation of basement membrane by MMPs; (ii) migration of blood endothelial cells (ECs); (iii) growth of ECs induced by growth factors such as bFGF and vascular endothelial growth factor (VEGF); (iv) tube formation of ECs and (v) the maturation of tube to vessel. Thus, each process of angiogenesis should be a target for development of antitumor and anti-inflammatory agents. In fact, TNP-4708), which shows very strong inhibitory activity against growth contained in integrins and kinase inhibitors of VEGF receptors13) have been developed in clinical trials.
We have screened for angiogenesis inhibitors, which exhibit inhibitory activity against the growth of HUVECs induced by bFGF, among metabolites of microorganisms.
In the course of screening, ICM0301A (1), B (2), C (3), D (4), E (5), F (6), G (7) and H (8) (Fig. 1) were isolated from the culture broth of Aspergillus sp. F-1491. In this paper, we describe the taxonomy of the producing organism, and the fermentation, isolation and biological activities of ICM0301s.
Materials and Methods

Materials
Inertsil ODS-3 columns and silica gel were obtained from GL Science (Tokyo, Japan) and Wako Chemical (Osaka, Japan), respectively. 
Anti-microbial Activity and Toxicity in Mice
Anti-fungal activities of ICM0301s were measured by the agar dilution method. Compound 1 was dissolved in 5% DMSO-saline solution and injected to female ICR mice intraperitoneally. Body weight changes of mice were monitored for 2 weeks.
Results and Discussion
Taxonomic Studies
The fungal strain F-1491 was cultured on various media summarized in Table 1 . For media tested the growth rates of the strain F-1491 were greatest on medium CYA. Colony surfaces on every media were flat to centrally raised, cottony to felty and white to reddish gray color. Soluble pigment was not found in the culture on every media.
Morphological characteristics (Fig. 2) of the strain were The isolation procedure of ICM0301s is shown in Fig. 3 .
After the fermentation, broth (130 liters (10mg) and 7 (10mg) as white powders, respectively. The fraction containing 8 was dissolved in a small volume of toluene and applied on a silica gel column (400ml). After washing with toluene-acetone (5:1, 1 liter), active ingredients were eluted with toluene-acetone (3:1, 1 liter)
to give a yellow powder (0.8g). This powder was applied on a preparative HPLC, and eluted with 35% acetonitrile at a flow rate of 7ml/minute to give 8 (15mg) as a white powder.
The retention time and Rf value of ICM0301s are summarized in Table 2 .
Physico-chemical properties and structure elucidation of ICM0301s will be described in a following paper.
Growth Inhibitory Activities against Human Cells Growth inhibitory activities of ICM0301s against
HUVECs and human tumor cell lines were assessed. As shown in Table 3 , ICM0301s showed potent inhibitory activities against HUVECs. Among them, ICM0301A (1) showed the strongest inhibitory activity against HUVECs
On the other hand, ICM0301s had no significant lines including H226, DLC-1, HT-1080. ICM0301s showed weak cytotoxicities against K562 cells.
Anti-angiogenic Activities in Rat Aorta Organ Culture
Anti-angiogenic activity of ICM0301A (1) was assessed by using the in vitro angiogenesis model of culturing fragment of rat aorta in three-dimensional fibrin gels. As shown in Fig. 4 , 1 exhibited dose dependent antiangiogenic activity, and showed significant inhibitory angiogenesis inhibitor through methinone amino-peptidase inhibition19), showed complete inhibition at 10ng/ml. It is known that anti-proliferative agents against ECs, MMP inhibitors20), hydrocortisone17), and endogenous [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] 2001 
